Global Animal Stem Cell Therapy 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI05251814

Publication Date:

May 5, 2025

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Animal Stem Cell Therapy market size is predicted to grow from US$ 286 million in 2025 to US$ 602 million in 2031; it is expected to grow at a CAGR of 13.2% from 2025 to 2031.
Animal stem cell therapy is a usage of animal鈥檚 stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
The animal stem cell therapy market is driven by increasing demand for advanced veterinary treatments, particularly for chronic and age-related conditions in pets and livestock. Stem cell therapies offer the potential to treat a variety of ailments such as osteoarthritis, tendon injuries, and organ degeneration, which are common in aging animals. As pet owners increasingly seek non-invasive, effective solutions for their animals' health problems, veterinary clinics and research institutions are advancing their stem cell therapy offerings. Furthermore, growing awareness of the benefits of regenerative medicine is helping to propel market growth in both companion animals and livestock sectors.
However, the market also faces several challenges. One of the key barriers is the high cost of stem cell therapies, which can limit accessibility for pet owners and smaller veterinary clinics. Additionally, the regulatory landscape for animal stem cell treatments is still evolving, which can create uncertainties around approval processes and standardization. There is also a lack of long-term clinical data supporting the effectiveness and safety of stem cell therapies, which can lead to hesitation among veterinarians and animal owners. These factors may slow down the widespread adoption of stem cell therapy in the veterinary field.
The 鈥淎nimal Stem Cell Therapy Industry Forecast鈥� looks at past sales and reviews total world Animal Stem Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Stem Cell Therapy sales for 2025 through 2031. With Animal Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Stem Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Animal Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Animal Stem Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Stem Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Stem Cell Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Stem Cell Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others
Segmentation by Application:
Veterinary Hospitals
Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Animal Stem Cell Therapy 麻豆原创 Size (2020-2031)
2.1.2 Animal Stem Cell Therapy 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Animal Stem Cell Therapy by Country/Region (2020, 2024 & 2031)
2.2 Animal Stem Cell Therapy Segment by Type
2.2.1 Dogs Stem Cell Therapy
2.2.2 Horses Stem Cell Therapy
2.2.3 Others
2.3 Animal Stem Cell Therapy 麻豆原创 Size by Type
2.3.1 Animal Stem Cell Therapy 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Animal Stem Cell Therapy 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Animal Stem Cell Therapy Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Research Organizations
2.5 Animal Stem Cell Therapy 麻豆原创 Size by Application
2.5.1 Animal Stem Cell Therapy 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Animal Stem Cell Therapy 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Animal Stem Cell Therapy 麻豆原创 Size by Player
3.1 Animal Stem Cell Therapy 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Animal Stem Cell Therapy Revenue by Player (2020-2025)
3.1.2 Global Animal Stem Cell Therapy Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Animal Stem Cell Therapy Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Animal Stem Cell Therapy by Region
4.1 Animal Stem Cell Therapy 麻豆原创 Size by Region (2020-2025)
4.2 Global Animal Stem Cell Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Animal Stem Cell Therapy 麻豆原创 Size Growth (2020-2025)
4.4 APAC Animal Stem Cell Therapy 麻豆原创 Size Growth (2020-2025)
4.5 Europe Animal Stem Cell Therapy 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Animal Stem Cell Therapy 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Animal Stem Cell Therapy 麻豆原创 Size by Country (2020-2025)
5.2 Americas Animal Stem Cell Therapy 麻豆原创 Size by Type (2020-2025)
5.3 Americas Animal Stem Cell Therapy 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal Stem Cell Therapy 麻豆原创 Size by Region (2020-2025)
6.2 APAC Animal Stem Cell Therapy 麻豆原创 Size by Type (2020-2025)
6.3 APAC Animal Stem Cell Therapy 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Animal Stem Cell Therapy 麻豆原创 Size by Country (2020-2025)
7.2 Europe Animal Stem Cell Therapy 麻豆原创 Size by Type (2020-2025)
7.3 Europe Animal Stem Cell Therapy 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Animal Stem Cell Therapy by Region (2020-2025)
8.2 Middle East & Africa Animal Stem Cell Therapy 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Animal Stem Cell Therapy 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Animal Stem Cell Therapy 麻豆原创 Forecast
10.1 Global Animal Stem Cell Therapy Forecast by Region (2026-2031)
10.1.1 Global Animal Stem Cell Therapy Forecast by Region (2026-2031)
10.1.2 Americas Animal Stem Cell Therapy Forecast
10.1.3 APAC Animal Stem Cell Therapy Forecast
10.1.4 Europe Animal Stem Cell Therapy Forecast
10.1.5 Middle East & Africa Animal Stem Cell Therapy Forecast
10.2 Americas Animal Stem Cell Therapy Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Animal Stem Cell Therapy Forecast
10.2.2 Canada 麻豆原创 Animal Stem Cell Therapy Forecast
10.2.3 Mexico 麻豆原创 Animal Stem Cell Therapy Forecast
10.2.4 Brazil 麻豆原创 Animal Stem Cell Therapy Forecast
10.3 APAC Animal Stem Cell Therapy Forecast by Region (2026-2031)
10.3.1 China Animal Stem Cell Therapy 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Animal Stem Cell Therapy Forecast
10.3.3 Korea 麻豆原创 Animal Stem Cell Therapy Forecast
10.3.4 Southeast Asia 麻豆原创 Animal Stem Cell Therapy Forecast
10.3.5 India 麻豆原创 Animal Stem Cell Therapy Forecast
10.3.6 Australia 麻豆原创 Animal Stem Cell Therapy Forecast
10.4 Europe Animal Stem Cell Therapy Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Animal Stem Cell Therapy Forecast
10.4.2 France 麻豆原创 Animal Stem Cell Therapy Forecast
10.4.3 UK 麻豆原创 Animal Stem Cell Therapy Forecast
10.4.4 Italy 麻豆原创 Animal Stem Cell Therapy Forecast
10.4.5 Russia 麻豆原创 Animal Stem Cell Therapy Forecast
10.5 Middle East & Africa Animal Stem Cell Therapy Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Animal Stem Cell Therapy Forecast
10.5.2 South Africa 麻豆原创 Animal Stem Cell Therapy Forecast
10.5.3 Israel 麻豆原创 Animal Stem Cell Therapy Forecast
10.5.4 Turkey 麻豆原创 Animal Stem Cell Therapy Forecast
10.6 Global Animal Stem Cell Therapy Forecast by Type (2026-2031)
10.7 Global Animal Stem Cell Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Animal Stem Cell Therapy Forecast
11 Key Players Analysis
11.1 Ardent Animal Health
11.1.1 Ardent Animal Health Company Information
11.1.2 Ardent Animal Health Animal Stem Cell Therapy Product Offered
11.1.3 Ardent Animal Health Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Ardent Animal Health Main Business Overview
11.1.5 Ardent Animal Health Latest Developments
11.2 VetStem
11.2.1 VetStem Company Information
11.2.2 VetStem Animal Stem Cell Therapy Product Offered
11.2.3 VetStem Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 VetStem Main Business Overview
11.2.5 VetStem Latest Developments
11.3 Medrego
11.3.1 Medrego Company Information
11.3.2 Medrego Animal Stem Cell Therapy Product Offered
11.3.3 Medrego Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Medrego Main Business Overview
11.3.5 Medrego Latest Developments
11.4 Vetbiologics
11.4.1 Vetbiologics Company Information
11.4.2 Vetbiologics Animal Stem Cell Therapy Product Offered
11.4.3 Vetbiologics Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Vetbiologics Main Business Overview
11.4.5 Vetbiologics Latest Developments
11.5 Vetherapy
11.5.1 Vetherapy Company Information
11.5.2 Vetherapy Animal Stem Cell Therapy Product Offered
11.5.3 Vetherapy Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Vetherapy Main Business Overview
11.5.5 Vetherapy Latest Developments
11.6 Celavet
11.6.1 Celavet Company Information
11.6.2 Celavet Animal Stem Cell Therapy Product Offered
11.6.3 Celavet Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Celavet Main Business Overview
11.6.5 Celavet Latest Developments
11.7 Magellan Stem Cells
11.7.1 Magellan Stem Cells Company Information
11.7.2 Magellan Stem Cells Animal Stem Cell Therapy Product Offered
11.7.3 Magellan Stem Cells Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Magellan Stem Cells Main Business Overview
11.7.5 Magellan Stem Cells Latest Developments
11.8 Animal General
11.8.1 Animal General Company Information
11.8.2 Animal General Animal Stem Cell Therapy Product Offered
11.8.3 Animal General Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Animal General Main Business Overview
11.8.5 Animal General Latest Developments
11.9 Stem Care Company
11.9.1 Stem Care Company Company Information
11.9.2 Stem Care Company Animal Stem Cell Therapy Product Offered
11.9.3 Stem Care Company Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Stem Care Company Main Business Overview
11.9.5 Stem Care Company Latest Developments
11.10 Animal Cell Therapies
11.10.1 Animal Cell Therapies Company Information
11.10.2 Animal Cell Therapies Animal Stem Cell Therapy Product Offered
11.10.3 Animal Cell Therapies Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Animal Cell Therapies Main Business Overview
11.10.5 Animal Cell Therapies Latest Developments
11.11 Cell Therapy Sciences
11.11.1 Cell Therapy Sciences Company Information
11.11.2 Cell Therapy Sciences Animal Stem Cell Therapy Product Offered
11.11.3 Cell Therapy Sciences Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Cell Therapy Sciences Main Business Overview
11.11.5 Cell Therapy Sciences Latest Developments
11.12 Animacel
11.12.1 Animacel Company Information
11.12.2 Animacel Animal Stem Cell Therapy Product Offered
11.12.3 Animacel Animal Stem Cell Therapy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Animacel Main Business Overview
11.12.5 Animacel Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.